{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/corteva-ctva/",
 "dataUrl": "https://clearank.com/stock/corteva-ctva/data.json",
 "title": "Corteva (CTVA) Stock Forecast & Price Target (2026)",
 "description": "CTVA stock forecast and price target 2026: is Corteva a buy? Pays a dividend. Industry: agricultural inputs; listed on the NYSE.",
 "headline": "Corteva Inc. (CTVA)",
 "published": "2026-11-09T18:16:31+00:00",
 "modified": "2026-11-09T18:16:31.399+00:00",
 "generated": "2026-11-11T13:24:39.494Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by Kate Leaman, Financial Journalist and Market Analyst; prices delayed by up to a minute.",
 "asset": {
  "ticker": "CTVA",
  "name": "Corteva Inc.",
  "type": "Common Stock",
  "exchange": "NYSE",
  "currency": "USD",
  "sector": "Basic Materials",
  "industry": "Agricultural Inputs",
  "country": "United States",
  "website": "https://www.corteva.com"
 },
 "quote": {
  "price": 12.17,
  "previousClose": 12.11,
  "change": 0.06,
  "changePercent": 0.4955,
  "open": 12.02,
  "high": 12.355,
  "low": 11.84,
  "volume": 11614094,
  "averageVolume": 22624359,
  "marketCap": 8119775320,
  "fiftyTwoWeekHigh": 14.62,
  "fiftyTwoWeekLow": 9.53638,
  "marketOpen": false,
  "asOf": "2026-11-10T23:38:36.000Z"
 },
 "statistics": {
  "pe": null,
  "eps": null,
  "dividendYield": 0.05916187345932621,
  "beta": null,
  "priceToSales": 1.6263574,
  "priceToBook": 0.99720025,
  "revenueTtm": 4968000000,
  "grossMargin": null,
  "returnOnEquity": 0.044861805954236035
 },
 "technicals": {
  "rsi": 48.67,
  "macd": -0.1656,
  "sma50": 12.48,
  "sma200": 12.14,
  "rsiSignal": "Neutral",
  "trend": "Bullish",
  "pricePosition": "Bearish",
  "macdSignal": "Bearish",
  "rating": "Neutral"
 },
 "analysis": {
  "rating": "Hold",
  "score": 55,
  "consensus": "Hold",
  "fairValue": null,
  "analystTarget": 17,
  "analystCount": 13,
  "wallStreetConsensus": "Buy",
  "generatedAt": "2026-11-10T23:38:36.000Z",
  "priceAtAnalysis": 12.17,
  "volatility": {
   "daily": 3.71,
   "risk": "volatile"
  }
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 8.68,
    "base": 13.28,
    "upside90th": 20.33
   },
   {
    "year": 2028,
    "downside10th": 7.94,
    "base": 14.5,
    "upside90th": 26.47
   },
   {
    "year": 2029,
    "downside10th": 7.57,
    "base": 15.83,
    "upside90th": 33.08
   },
   {
    "year": 2030,
    "downside10th": 7.38,
    "base": 17.28,
    "upside90th": 40.48
   }
  ]
 },
 "faqCount": 6,
 "atAGlance": {
  "asOf": "November 10, 2026",
  "rating": "Hold",
  "score": 55,
  "evidence": [
   {
    "label": "Trend",
    "text": "Mixed: the price is above its 200-day but below its 50-day moving average ($12.14 and $12.48)."
   },
   {
    "label": "Earnings",
    "text": "CTVA beat estimates in 6 of its last 7 quarters, yet fell in the first session after 4 of those beats."
   },
   {
    "label": "Insiders",
    "text": "Insiders sold $7.2M and made no open-market purchases over the last 18 months."
   }
  ]
 },
 "figures": {
  "asOf": "November 10, 2026",
  "earningsReaction": {
   "quarters": 7,
   "beats": 6,
   "fellFirstSessionAfterBeat": 4,
   "latestReport": "Jul 30, 2026",
   "latestSurprisePercent": 3.14,
   "latestFirstSessionMovePercent": -11.9
  },
  "insiders": {
   "windowMonths": 18,
   "soldValue": 7161964,
   "boughtValue": 0,
   "sales": 3,
   "purchases": 0,
   "note": "open-market transactions only; grants and option exercises excluded"
  },
  "drawdown": {
   "years": 7,
   "worstFallPercent": -29.46,
   "peak": "November 2022",
   "trough": "November 2023",
   "recoveredBy": "September 2024",
   "recoveryMonths": 10,
   "belowThatPeakNowPercent": null,
   "fromHighNowPercent": -15.78,
   "oneYearHoldsPositivePercent": 88,
   "dividendsReinvested": true
  },
  "seasonality": {
   "years": 8,
   "bestMonth": {
    "month": "Feb",
    "averagePercent": 6.64,
    "upYearsPercent": 71
   },
   "worstMonth": {
    "month": "Sep",
    "averagePercent": -2.51,
    "upYearsPercent": 38
   }
  },
  "correlations": null,
  "analystTargets": {
   "analysts": 13,
   "low": 13.65,
   "median": 17,
   "high": 20,
   "mean": 17.13,
   "buy": 11,
   "hold": 2,
   "sell": 0
  },
  "dividend": {
   "yieldPercent": 5.92,
   "annualPerShare": 0.72
  },
  "simulation": {
   "year": 2030,
   "base": 17.28,
   "percentile10": 7.38,
   "percentile90": 40.48,
   "note": "Monte Carlo simulation outcomes, not price targets"
  }
 },
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "ch-overview",
   "title": "CTVA stock today, November 11, 2026: price, news and analyst targets",
   "text": [
    "As of November 10, 2026, Corteva Inc. (CTVA) trades at $12.17. Wall Street's median 12-month price target is $17.00 across 13 analysts, 39.7% above the price. CleaRank rates it Hold with a score of 55/100.",
    "Corteva has been trading in a narrow band just above its 200-day average, and the next move will likely be decided by whether the stock can clear its 50-day average. The price of $12.17 sits 0.27% above the 200-day SMA of $12.14 and 2.48% below the 50-day SMA of $12.48, so the trend signals point in different directions. Analysts remain constructive: 11 of 13 rate the stock Buy, and the median 12-month target is $17.00. CleaRank's own rating is Hold, at 55 out of 100, because revenue shrank in the most recent available quarter and profitability trails the sector.",
    "Of the six recent rating actions, three were reaffirmations of a constructive stance, and two of those were upgrades to a buy-type view. JP Morgan upgraded the stock to Overweight from Neutral on October 6, 2026, and Keybanc upgraded it to Overweight from Sector Weight on October 7, 2026. UBS kept its Neutral rating on October 12, 2026. Argus Research kept its Buy rating on September 18, 2026, and BMO Capital kept its Outperform rating on September 16, 2026. Citigroup kept its Neutral rating on September 17, 2026. Eleven of the 13 analysts with a current rating now rate the stock buy or strong buy, while 15 of 22 ratings three months earlier were buys. The shift toward Buy is real, but two analysts still hold a neutral view and none rate it sell.",
    "Corteva beat the EPS estimate in six of its last seven reports. The July 30, 2026 report beat by 3.14%, with adjusted EPS of $2.30 against $2.23 expected, yet the stock fell 11.90% in the first session after that report. The May 5, 2026 report beat by 27.12% and the stock fell 2.54% the next session. In four of the six beats, the share price was lower in the first session after the report. Investors appear to be focused on sales and forward guidance rather than on the EPS beat alone.",
    "At a price-to-sales ratio of 1.63, the stock trades 61.2% below the sector median P/S of 4.2, on a market capitalisation of $8.1B. That discount reflects weak fundamentals. Revenue growth trails the sector median of 19.0% by 20.2 percentage points, and the net profit margin is 2.5%, while return on equity of 4.49% sits well below the sector median of 17.9%. The debt-to-equity ratio of 0.57 is moderate. The trailing dividend yield is 5.92%, paid at an annual $0.72 per share, which gives income-focused holders a return while they wait for growth to come back.",
    "Insiders sold $7.2M of stock across three sales over the last 18 months, and there were no open-market purchases in that period. Insider sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than purchases would. The RSI reads 48.7, which is neutral, and the MACD line is negative. The stock fell 8.08% over one month and rose 23.72% over one year, so the longer-term direction has been positive while the most recent month has been weak.",
    "CleaRank score 55/100 (Hold). 14 of 18 checks pass: trend 3 of 4, momentum 1 of 3, valuation and quality 4 of 4, analysts 3 of 3, track record 3 of 4.",
    "Corteva Inc. is a global agricultural science company that develops and supplies seed and crop protection solutions for farmers and agribusinesses. Its product portfolio includes advanced seed genetics, trait technologies, herbicides, insecticides, fungicides, biologicals, and seed-applied technologies designed to support crop performance, pest control, and plant health. The company serves a wide range of agricultural markets, including field crops such as corn and soybeans, as well as specialty crops and pasture management needs. Corteva Inc."
   ]
  },
  {
   "id": "ch-news",
   "title": "CTVA stock news",
   "text": [
    "October 6, 2026·JP Morgan",
    "JP Morgan moved the stock to Overweight from Neutral on October 6, 2026. A second upgrade from Keybanc followed the next day, and together they add to the buy-side support that drives the consensus.",
    "October 7, 2026·Keybanc",
    "Keybanc moved the stock to Overweight from Sector Weight on October 7, 2026. Two upgrades in quick succession signal that the analyst view is shifting toward the growth case.",
    "UBS kept its Neutral rating on October 12, 2026. The stance shows that not every firm is convinced the growth case is priced in, and that the buy-side view is not unanimous.",
    "September 17, 2026·Citigroup",
    "Citigroup kept its Neutral rating on September 17, 2026. Like UBS, it keeps the neutral camp at two firms and shows that the upgrade wave has not reached every analyst.",
    "September 18, 2026·Argus Research",
    "Argus Research kept its Buy rating on September 18, 2026. A reaffirmed Buy from an established research firm supports the constructive consensus behind the $17.00 median target."
   ],
   "lists": {
    "items": [
     "Upgrade to Overweight from a neutral stance October 6, 2026·JP Morgan JP Morgan moved the stock to Overweight from Neutral on October 6, 2026. A second upgrade from Keybanc followed the next day, and together they add to the buy-side support that drives the consensus.",
     "Second upgrade in two days October 7, 2026·Keybanc Keybanc moved the stock to Overweight from Sector Weight on October 7, 2026. Two upgrades in quick succession signal that the analyst view is shifting toward the growth case.",
     "UBS keeps its neutral view October 12, 2026·UBS UBS kept its Neutral rating on October 12, 2026. The stance shows that not every firm is convinced the growth case is priced in, and that the buy-side view is not unanimous.",
     "Citigroup holds neutral September 17, 2026·Citigroup Citigroup kept its Neutral rating on September 17, 2026. Like UBS, it keeps the neutral camp at two firms and shows that the upgrade wave has not reached every analyst.",
     "Argus keeps Buy rating September 18, 2026·Argus Research Argus Research kept its Buy rating on September 18, 2026. A reaffirmed Buy from an established research firm supports the constructive consensus behind the $17.00 median target."
    ]
   }
  },
  {
   "id": "ch-street",
   "title": "CTVA price target 2026",
   "text": [
    "The base case for the coming months is a stock that stays range-bound while it proves it can grow again. The price needs to hold above the 200-day average and then reclaim the 50-day average to shift the trend signal to positive. Revenue growth is the main gap: the most recent available quarter shrank 1.20% year on year against a sector median of 19.0%, so analysts' expected 4.7% EPS growth for next year will need to show up in sales. Analysts' targets run from $13.65 to $20.00, with a median of $17.00, and that median assumes the growth case position out. A sustained break below the 200-day average would weaken the case and bring the $9.54 52-week low back into view as a reference. A clear move above the 50-day average, with momentum turning positive, would strengthen it. The CleaRank view is based on the figures above and is not a forecast."
   ],
   "tables": [
    {
     "caption": "Recent analyst rating actions on CTVA",
     "columns": [
      "Date",
      "Firm",
      "Action",
      "Rating"
     ],
     "rows": [
      {
       "label": "Oct 12, 2026",
       "cells": [
        "UBS",
        "Maintains",
        "Neutral"
       ]
      },
      {
       "label": "Oct 7, 2026",
       "cells": [
        "Keybanc",
        "Upgrade",
        "Overweight"
       ]
      },
      {
       "label": "Oct 6, 2026",
       "cells": [
        "JP Morgan",
        "Upgrade",
        "Overweight"
       ]
      },
      {
       "label": "Sep 18, 2026",
       "cells": [
        "Argus Research",
        "Reiterates",
        "Buy"
       ]
      },
      {
       "label": "Sep 17, 2026",
       "cells": [
        "Citigroup",
        "Maintains",
        "Neutral"
       ]
      },
      {
       "label": "Sep 16, 2026",
       "cells": [
        "BMO Capital",
        "Maintains",
        "Outperform"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "ch-levels",
   "title": "CTVA support and resistance levels",
   "text": [
    "Support: the 200-day SMA at $12.14 is the nearest level below the price, and a fall would meet it first. Below that, the 52-week low at $9.54 is the next floor, the level where the stock last bottomed. Resistance: the 20-day EMA at $12.19 sits just above the price and is the first level a rise would meet. The 50-day SMA at $12.48 comes next and is the level the trend signal depends on. Above it, the 52-week high at $14.62 is the level a sustained rally would have to reach."
   ],
   "tables": [
    {
     "caption": "CTVA support and resistance levels",
     "columns": [
      "Level",
      "What it is",
      "Price",
      "From the price"
     ],
     "rows": [
      {
       "label": "Resistance 3",
       "cells": [
        "52-week high",
        "$14.62",
        "+20.1%"
       ]
      },
      {
       "label": "Resistance 2",
       "cells": [
        "50-day moving average",
        "$12.48",
        "+2.5%"
       ]
      },
      {
       "label": "Resistance 1",
       "cells": [
        "20-day exponential average",
        "$12.19",
        "+0.2%"
       ]
      },
      {
       "label": "Price",
       "cells": [
        "November 10, 2026",
        "$12.17",
        ""
       ]
      },
      {
       "label": "Support 1",
       "cells": [
        "200-day moving average",
        "$12.14",
        "-0.3%"
       ]
      },
      {
       "label": "Support 2",
       "cells": [
        "52-week low",
        "$9.54",
        "-21.6%"
       ]
      }
     ]
    }
   ],
   "lists": {
    "items": [
     "RSI Neutral",
     "SMA cross Bullish",
     "Price vs SMA Bearish",
     "MACD Bearish"
    ]
   }
  },
  {
   "id": "ch-price",
   "title": "CTVA stock price and trading"
  },
  {
   "id": "ch-fundamentals",
   "title": "CTVA fundamentals and valuation",
   "text": [
    "Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, CTVA trades at 1.63x, -61% versus the sector median of 4.20x.",
    "Return vs XLB: Since May 30, 2025, CTVA has gained 14.6% against a gain of 22.4% for XLB.",
    "Revenue growth: Revenue grew 2.9% in FY2025 to $17.4B, from $16.9B a year earlier.",
    "Profit margin: The net margin was 6.4% in FY2025, up from 5.4% the year before.",
    "Profitable: CTVA earned $1.1B in FY2025.",
    "Earnings record: CTVA beat the analyst estimate in 6 of the 7 reports in our data.",
    "Market reaction: The stock fell in the first session after 4 of those 6 beats, so a beat has not been enough on its own."
   ],
   "tables": [
    {
     "caption": "CTVA earnings surprises and the stock's reaction",
     "columns": [
      "Report",
      "Estimate",
      "Actual",
      "Surprise",
      "First sessionDay 1",
      "5 sessionsDay 5"
     ],
     "rows": [
      {
       "label": "Jul 30, 2026",
       "cells": [
        "$2.23",
        "$2.30",
        "+3.14%",
        "-11.90%",
        "-13.97%"
       ]
      },
      {
       "label": "May 5, 2026",
       "cells": [
        "$1.18",
        "$1.50",
        "+27.12%",
        "-2.54%",
        "-1.56%"
       ]
      },
      {
       "label": "Feb 3, 2026",
       "cells": [
        "$0.22",
        "$0.22",
        "+0.00%",
        "+0.11%",
        "-1.09%"
       ]
      },
      {
       "label": "Nov 4, 2025",
       "cells": [
        "-$0.47",
        "-$0.23",
        "+51.06%",
        "+1.87%",
        "+5.15%"
       ]
      },
      {
       "label": "Aug 6, 2025",
       "cells": [
        "$1.88",
        "$2.20",
        "+17.02%",
        "-0.17%",
        "+1.63%"
       ]
      },
      {
       "label": "May 7, 2025",
       "cells": [
        "$0.88",
        "$1.13",
        "+28.41%",
        "+7.01%",
        "+8.18%"
       ]
      },
      {
       "label": "Feb 5, 2025",
       "cells": [
        "$0.31",
        "$0.32",
        "+3.23%",
        "-2.29%",
        "-2.76%"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "ch-history",
   "title": "CTVA price history and drawdowns",
   "text": [
    "Against the market: CTVA beat the S&P 500 over this period: $59,001 against $30,573.",
    "A $10,000 investment in CTVA in June 2019 would be worth about $59,001 today with dividends reinvested, compared with about $30,573 for the same investment in the S&P 500 benchmark (also with dividends reinvested)."
   ]
  },
  {
   "id": "ch-scenarios",
   "title": "CTVA stock price prediction 2030",
   "text": [
    "CleaRank's simulation projects a price near $17.28 for CTVA by 2030 in the base case, from $12.17 today (1.4x over 4 years). The 10th-percentile path ends near $7.38. These are outcomes of a Monte Carlo simulation run on CTVA's historical return distribution, not price targets, and they assume no dividends are reinvested."
   ],
   "tables": [
    {
     "caption": "CTVA simulated price paths by year",
     "columns": [
      "Year",
      "10th percentile",
      "Base case",
      "90th percentile",
      "range base today"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$8.68",
        "$13.28",
        "$20.33",
        ""
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$7.94",
        "$14.50",
        "$26.47",
        ""
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$7.57",
        "$15.83",
        "$33.08",
        ""
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$7.38",
        "$17.28",
        "$40.48",
        ""
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "ch-insiders",
   "title": "CTVA insider trading",
   "text": [
    "Net insider selling: No insider bought CTVA shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would."
   ],
   "tables": [
    {
     "caption": "Insider transactions in CTVA",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "Oct 30, 2026",
       "cells": [
        "Nayaki R Nayyar Director",
        "Grant",
        "2.8K",
        "$32.5K"
       ]
      },
      {
       "label": "Jul 31, 2026",
       "cells": [
        "Janet Plaut Giesselman Director",
        "Grant",
        "98",
        "$7.8K"
       ]
      },
      {
       "label": "Jul 31, 2026",
       "cells": [
        "Nayaki R Nayyar Director",
        "Grant",
        "412",
        "$32.5K"
       ]
      },
      {
       "label": "Jul 31, 2026",
       "cells": [
        "Christopher J Policinski Director",
        "Grant",
        "412",
        "$32.5K"
       ]
      },
      {
       "label": "Jun 1, 2026",
       "cells": [
        "Luther C Kissam IV Chief Executive Officer",
        "Grant",
        "24.1K",
        "-"
       ]
      },
      {
       "label": "Apr 30, 2026",
       "cells": [
        "Janet Plaut Giesselman Director",
        "Grant",
        "95",
        "$7.8K"
       ]
      },
      {
       "label": "Apr 30, 2026",
       "cells": [
        "Nayaki R Nayyar Director",
        "Grant",
        "401",
        "$32.5K"
       ]
      },
      {
       "label": "Apr 28, 2026",
       "cells": [
        "Klaus A Engel Director",
        "Grant",
        "2.4K",
        "-"
       ]
      },
      {
       "label": "Apr 28, 2026",
       "cells": [
        "David C Everitt Director",
        "Grant",
        "2.4K",
        "-"
       ]
      },
      {
       "label": "Apr 28, 2026",
       "cells": [
        "Janet Plaut Giesselman Director",
        "Grant",
        "2.4K",
        "-"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "ch-faq",
   "title": "CTVA stock forecast: questions people ask",
   "text": [
    "How these figures are computed, and where the data comes from: CleaRank methodology."
   ]
  },
  {
   "id": "ch-related",
   "title": "Compare CTVA with similar assets",
   "links": [
    {
     "text": "DOW Dow Inc. NYSE $31.48 +1.68%",
     "url": "https://clearank.com/stock/dow-inc-dow/"
    },
    {
     "text": "PAAS Pan American Silver Corp. NYSE $39.89 -5.83%",
     "url": "https://clearank.com/stock/paas-stock-analysis/"
    },
    {
     "text": "ASPI ASP Isotopes Inc. NASDAQ $1.98 -7.48%",
     "url": "https://clearank.com/stock/aspi-asp-isotopes/"
    },
    {
     "text": "SHW The Sherwin-Williams Company NYSE $355.34 -0.72%",
     "url": "https://clearank.com/stock/shw-stock-analysis/"
    },
    {
     "text": "NUE Nucor Corporation NYSE $256.47 +2.90%",
     "url": "https://clearank.com/stock/nucor-nue/"
    },
    {
     "text": "CLF Cleveland-Cliffs Inc. NYSE $12.86 +4.89%",
     "url": "https://clearank.com/stock/clf-stock-analysis/"
    },
    {
     "text": "TMC TMC The Metals Company Inc. NASDAQ $2.42 -7.63%",
     "url": "https://clearank.com/stock/tmc-metals-company-tmc/"
    },
    {
     "text": "LYB LyondellBasell Industries N.V. NYSE $60.60 +1.85%",
     "url": "https://clearank.com/stock/lyondellbasell-lyb/"
    },
    {
     "text": "BTC vs ETH Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/btc-vs-eth/"
    },
    {
     "text": "MSFT vs TSLA Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/msft-vs-tsla/"
    },
    {
     "text": "GLD vs IAU Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/gld-vs-iau/"
    }
   ]
  }
 ],
 "faq": [
  {
   "question": "What is the CTVA stock forecast?",
   "answer": "The median 12-month analyst price target is $17.00, which is 39.7% above the current price of $12.17. Targets range from a low of $13.65 to a high of $20.00 across 13 analysts. The nearest level below the price is the 200-day SMA at $12.14, and the nearest level above it is the 20-day EMA at $12.19."
  },
  {
   "question": "What is the CTVA price target?",
   "answer": "The median 12-month analyst target is $17.00, with the lowest target at $13.65 and the highest at $20.00. The consensus rating is Buy, with 11 of 13 analysts rating the stock buy or strong buy. The price of $12.17 sits well below the median target."
  },
  {
   "question": "Is CTVA a buy or sell today?",
   "answer": "Analysts rate the stock Buy overall: 11 of 13 rate it buy or strong buy, 2 rate it hold, and none rate it sell. CleaRank's own rating is Hold, with a score of 55 out of 100. The price is 0.27% above the 200-day SMA and 2.48% below the 50-day SMA, so the trend signals are mixed."
  },
  {
   "question": "Why did the stock fall after its last earnings beat?",
   "answer": "The stock fell 11.90% in the first session after the July 30, 2026 report, even though adjusted EPS of $2.30 beat the $2.23 estimate by 3.14%. No cause for the drop has been reported, so the revenue trend is the figure most closely tied to investor concern."
  },
  {
   "question": "How much income does CTVA pay?",
   "answer": "The trailing dividend yield is 5.92%, based on an annual dividend of $0.72 per share. That yield is a trailing figure and depends on the current price of $12.17."
  },
  {
   "question": "Are insiders buying or selling CTVA?",
   "answer": "Insiders sold $7.2M of stock across three sales over the last 18 months. There were no open-market purchases in that period. Insider sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than purchases."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "DOW",
    "name": "Dow Inc. NYSE",
    "price": "$31.48",
    "change": "+1.68%",
    "url": "https://clearank.com/stock/dow-inc-dow/"
   },
   {
    "ticker": "PAAS",
    "name": "Pan American Silver Corp. NYSE",
    "price": "$39.89",
    "change": "-5.83%",
    "url": "https://clearank.com/stock/paas-stock-analysis/"
   },
   {
    "ticker": "ASPI",
    "name": "ASP Isotopes Inc. NASDAQ",
    "price": "$1.98",
    "change": "-7.48%",
    "url": "https://clearank.com/stock/aspi-asp-isotopes/"
   },
   {
    "ticker": "SHW",
    "name": "The Sherwin-Williams Company NYSE",
    "price": "$355.34",
    "change": "-0.72%",
    "url": "https://clearank.com/stock/shw-stock-analysis/"
   },
   {
    "ticker": "NUE",
    "name": "Nucor Corporation NYSE",
    "price": "$256.47",
    "change": "+2.90%",
    "url": "https://clearank.com/stock/nucor-nue/"
   },
   {
    "ticker": "CLF",
    "name": "Cleveland-Cliffs Inc. NYSE",
    "price": "$12.86",
    "change": "+4.89%",
    "url": "https://clearank.com/stock/clf-stock-analysis/"
   },
   {
    "ticker": "TMC",
    "name": "TMC The Metals Company Inc. NASDAQ",
    "price": "$2.42",
    "change": "-7.63%",
    "url": "https://clearank.com/stock/tmc-metals-company-tmc/"
   },
   {
    "ticker": "LYB",
    "name": "LyondellBasell Industries N.V. NYSE",
    "price": "$60.60",
    "change": "+1.85%",
    "url": "https://clearank.com/stock/lyondellbasell-lyb/"
   }
  ],
  "comparisons": [
   {
    "ticker": "BTC vs ETH Comparison",
    "name": "",
    "url": "https://clearank.com/compare/btc-vs-eth/"
   },
   {
    "ticker": "MSFT vs TSLA Comparison",
    "name": "",
    "url": "https://clearank.com/compare/msft-vs-tsla/"
   },
   {
    "ticker": "GLD vs IAU Comparison",
    "name": "",
    "url": "https://clearank.com/compare/gld-vs-iau/"
   }
  ],
  "Newly Tracked": [
   {
    "ticker": "HL",
    "text": "Hecla Mining Company",
    "url": "https://clearank.com/stock/hecla-mining-hl/"
   },
   {
    "ticker": "LYB",
    "text": "LyondellBasell Industries N.V.",
    "url": "https://clearank.com/stock/lyondellbasell-lyb/"
   },
   {
    "ticker": "VALE",
    "text": "Vale S.A.",
    "url": "https://clearank.com/stock/vale-vale/"
   },
   {
    "ticker": "ALB",
    "text": "Albemarle Corporation",
    "url": "https://clearank.com/stock/albemarle-alb/"
   },
   {
    "ticker": "XEL",
    "text": "Xcel Energy Inc.",
    "url": "https://clearank.com/stock/xcel-energy-xel/"
   }
  ],
  "Top Movers (latest session)": [
   {
    "ticker": "MRDN",
    "text": "↓ 23.90%",
    "url": "https://clearank.com/stock/mrdn-stock-analysis/"
   },
   {
    "ticker": "HIMS",
    "text": "↓ 16.61%",
    "url": "https://clearank.com/stock/hims-hers-health-hims/"
   },
   {
    "ticker": "LEGN",
    "text": "↓ 15.97%",
    "url": "https://clearank.com/stock/legend-biotech-legn/"
   },
   {
    "ticker": "PL",
    "text": "↑ 14.50%",
    "url": "https://clearank.com/stock/planet-labs-pl/"
   },
   {
    "ticker": "ZEC/USD",
    "text": "↓ 12.04%",
    "url": "https://clearank.com/crypto/zcash-zec-usd/"
   }
  ],
  "Also in Basic Materials": [
   {
    "ticker": "CF",
    "text": "CF Industries",
    "url": "https://clearank.com/stock/cf-industries-cf/"
   },
   {
    "ticker": "CLF",
    "text": "Cleveland-Cliffs Inc.",
    "url": "https://clearank.com/stock/clf-stock-analysis/"
   },
   {
    "ticker": "CX",
    "text": "Cemex",
    "url": "https://clearank.com/stock/cx-stock-analysis/"
   },
   {
    "ticker": "DOW",
    "text": "",
    "url": "https://clearank.com/stock/dow-inc-dow/"
   },
   {
    "ticker": "MOS",
    "text": "Mosaic",
    "url": "https://clearank.com/stock/mosaic-mos/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "alternateName": [
      "CleaRank Financial AI",
      "CleaRank (Clear Rank)"
     ],
     "url": "https://clearank.com",
     "description": "CleaRank is where retail traders research a trade and practice it before risking money. Its research arm, CleaRank Financial AI, publishes daily analysis and 10-year projections for more than 1,000 stocks, ETFs, cryptocurrencies, forex pairs and commodities; each page is built from licensed market data, carries the date it was last updated and is reviewed under CleaRank's published editorial code. The CLEAR™ Score rates online brokers and prop firms on regulation, fees, platform reliability and verified trader experience. The research is free, and so is the Free plan of its trading workbench; CleaRank is paid for by yearly Pro and Unlimited subscriptions to that workbench, which combines a trading simulator, a trade journal that imports from broker history, an AI coach grounded in the trader's own trades, a portfolio generator, visualizer and backtester, a prop-firm challenge auditor and 22 trading calculators and scanners. It uses no affiliate links and takes no payment from the brokers, prop firms or companies it rates or writes about.",
     "slogan": "Clear data. Honest analysis.",
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "image": {
      "@id": "https://clearank.com/#logo"
     },
     "sameAs": [
      "https://x.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank",
      "https://t.me/clearank"
     ],
     "email": "info@clearank.com",
     "contactPoint": [
      {
       "@type": "ContactPoint",
       "contactType": "customer support",
       "email": "info@clearank.com",
       "url": "https://clearank.com/contact/",
       "availableLanguage": "en"
      }
     ],
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "location": {
      "@type": "Place",
      "@id": "https://clearank.com/#place",
      "address": {
       "@type": "PostalAddress",
       "streetAddress": "Beni Berman 2",
       "addressLocality": "Netanya",
       "addressRegion": "Center",
       "postalCode": "4249330",
       "addressCountry": "IL"
      }
     },
     "knowsAbout": [
      "stock analysis",
      "ETF analysis",
      "cryptocurrency analysis",
      "forex trading",
      "trading simulation",
      "trade journaling",
      "position sizing",
      "risk management",
      "prop firm challenges",
      "online broker regulation"
     ],
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "ethicsPolicy": "https://clearank.com/editorial-code/",
     "ownershipFundingInfo": "https://clearank.com/about-us/",
     "owns": {
      "@type": "SoftwareApplication",
      "@id": "https://clearank.com/#app",
      "name": "CleaRank",
      "url": "https://clearank.com/"
     },
     "founder": {
      "@type": "Person",
      "@id": "https://clearank.com/writer/shaundavidb/#person",
      "name": "Shaun David",
      "url": "https://clearank.com/writer/shaundavidb/"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/og/mi/stock/corteva-ctva.png",
     "url": "https://clearank.com/og/mi/stock/corteva-ctva.png",
     "width": "1200",
     "height": "630",
     "caption": "Corteva Inc. (CTVA) analysis by CleaRank",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/corteva-ctva/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": 1,
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": 2,
       "item": {
        "@id": "https://clearank.com/stock/",
        "name": "Stocks"
       }
      },
      {
       "@type": "ListItem",
       "position": 3,
       "item": {
        "@id": "https://clearank.com/stock/corteva-ctva/",
        "name": "Corteva Inc. (CTVA)"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/corteva-ctva/#webpage",
     "url": "https://clearank.com/stock/corteva-ctva/",
     "name": "Corteva (CTVA) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-11-09T18:16:31+00:00",
     "dateModified": "2026-11-09T18:16:31+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/og/mi/stock/corteva-ctva.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/corteva-ctva/#breadcrumb"
     },
     "reviewedBy": {
      "@id": "https://clearank.com/writer/kate-leaman/#person"
     }
    },
    {
     "@type": "Person",
     "@id": "https://clearank.com/writer/kate-leaman/#person",
     "name": "Kate Leaman",
     "jobTitle": "Financial Journalist and Market Analyst",
     "url": "https://clearank.com/writer/kate-leaman/",
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     }
    },
    {
     "@type": "Article",
     "@id": "https://clearank.com/stock/corteva-ctva/#richSnippet",
     "headline": "Corteva (CTVA) Stock Forecast & Price Target (2026)",
     "name": "Corteva (CTVA) Stock Forecast & Price Target (2026)",
     "description": "CTVA stock forecast and price target 2026: is Corteva a buy? Pays a dividend. Industry: agricultural inputs; listed on the NYSE.",
     "datePublished": "2026-11-09T18:16:31+00:00",
     "dateModified": "2026-11-09T18:16:31+00:00",
     "author": {
      "@id": "https://clearank.com/#organization"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "publishingPrinciples": "https://clearank.com/market-insights/methodology/",
     "about": {
      "@type": "Corporation",
      "name": "Corteva Inc.",
      "identifier": [
       {
        "@type": "PropertyValue",
        "propertyID": "tickerSymbol",
        "value": "CTVA"
       },
       {
        "@type": "PropertyValue",
        "propertyID": "exchange",
        "value": "NYSE"
       }
      ],
      "description": "Corteva Inc. is a global agricultural science company that develops and supplies seed and crop protection solutions for farmers and agribusinesses.",
      "tickerSymbol": "CTVA",
      "sameAs": "https://www.corteva.com"
     },
     "isPartOf": {
      "@id": "https://clearank.com/stock/corteva-ctva/#webpage"
     },
     "image": {
      "@type": "ImageObject",
      "url": "https://clearank.com/og/mi/stock/corteva-ctva.png",
      "width": 1200,
      "height": 630
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/corteva-ctva/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "What is the CTVA stock forecast?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The median 12-month analyst price target is $17.00, which is 39.7% above the current price of $12.17. Targets range from a low of $13.65 to a high of $20.00 across 13 analysts. The nearest level below the price is the 200-day SMA at $12.14, and the nearest level above it is the 20-day EMA at $12.19."
     }
    },
    {
     "@type": "Question",
     "name": "What is the CTVA price target?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The median 12-month analyst target is $17.00, with the lowest target at $13.65 and the highest at $20.00. The consensus rating is Buy, with 11 of 13 analysts rating the stock buy or strong buy. The price of $12.17 sits well below the median target."
     }
    },
    {
     "@type": "Question",
     "name": "Is CTVA a buy or sell today?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Analysts rate the stock Buy overall: 11 of 13 rate it buy or strong buy, 2 rate it hold, and none rate it sell. CleaRank's own rating is Hold, with a score of 55 out of 100. The price is 0.27% above the 200-day SMA and 2.48% below the 50-day SMA, so the trend signals are mixed."
     }
    },
    {
     "@type": "Question",
     "name": "Why did the stock fall after its last earnings beat?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The stock fell 11.90% in the first session after the July 30, 2026 report, even though adjusted EPS of $2.30 beat the $2.23 estimate by 3.14%. No cause for the drop has been reported, so the revenue trend is the figure most closely tied to investor concern."
     }
    },
    {
     "@type": "Question",
     "name": "How much income does CTVA pay?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The trailing dividend yield is 5.92%, based on an annual dividend of $0.72 per share. That yield is a trailing figure and depends on the current price of $12.17."
     }
    },
    {
     "@type": "Question",
     "name": "Are insiders buying or selling CTVA?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Insiders sold $7.2M of stock across three sales over the last 18 months. There were no open-market purchases in that period. Insider sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than purchases."
     }
    }
   ]
  }
 ]
}